tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Roche price target lowered to CHF 220 from CHF 230 at JPMorgan
The FlyRoche price target lowered to CHF 220 from CHF 230 at JPMorgan
3d ago
CHRO
Roche granted FDA BDD for VENTANA TROP2 RxDx Device
PremiumThe Fly
Roche granted FDA BDD for VENTANA TROP2 RxDx Device
4d ago
CHRO
Roche price target lowered to CHF 250 from CHF 265 at Deutsche Bank
PremiumThe Fly
Roche price target lowered to CHF 250 from CHF 265 at Deutsche Bank
5d ago
CHRO
Roche downgraded to Hold from Buy at HSBC
PremiumThe Fly
Roche downgraded to Hold from Buy at HSBC
5d ago
CHRO
Roche price target lowered to CHF 286 from CHF 312 at Morgan Stanley
PremiumThe Fly
Roche price target lowered to CHF 286 from CHF 312 at Morgan Stanley
8d ago
CHRO
Genentech announces CENTERSTONE trial data published in NEJM
PremiumThe FlyGenentech announces CENTERSTONE trial data published in NEJM
8d ago
CHRO
Trump Trade: Auto makers exempt from some U.S. tariffs
Premium
The Fly
Trump Trade: Auto makers exempt from some U.S. tariffs
9d ago
F
GM
Roche seeking U.S. tariff relief in direct talks with White House, Reuters says
Premium
The Fly
Roche seeking U.S. tariff relief in direct talks with White House, Reuters says
9d ago
CHRO
Roche Holding AG: Mixed Q1’25 Results and Strategic U.S. Investments Justify Hold Rating
PremiumRatings
Roche Holding AG: Mixed Q1’25 Results and Strategic U.S. Investments Justify Hold Rating
9d ago
CHRO
Roche sees FY25 core EPS growing in high single digit range
PremiumThe Fly
Roche sees FY25 core EPS growing in high single digit range
9d ago
CHRO
Roche reports Q1 group sales CHF 15.4B vs. CHF 14.4B last year
PremiumThe Fly
Roche reports Q1 group sales CHF 15.4B vs. CHF 14.4B last year
9d ago
CHRO
Trump looking at cutting drug prices to international levels, Reuters says
PremiumThe Fly
Trump looking at cutting drug prices to international levels, Reuters says
11d ago
AZN
BMY
Regeneron price target lowered to $850 from $1,152 at Canaccord
PremiumThe FlyRegeneron price target lowered to $850 from $1,152 at Canaccord
11d ago
AMGN
CHRO
Roche to invest $50B in pharmaceuticals, diagnostics in the U.S. over 5 years
Premium
The Fly
Roche to invest $50B in pharmaceuticals, diagnostics in the U.S. over 5 years
11d ago
CHRO
Roche announces EC has approved Columvi to treat large B-cell lymphoma
Premium
The Fly
Roche announces EC has approved Columvi to treat large B-cell lymphoma
19d ago
CHRO
Tempest Therapeutics downgraded at Scotiabank as amezalpat finds no suitors
PremiumThe Fly
Tempest Therapeutics downgraded at Scotiabank as amezalpat finds no suitors
23d ago
CHRO
TPST
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
PremiumThe Fly
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
24d ago
AZN
BMY
Roche price target raised to CHF 312 from CHF 305 at Morgan Stanley
PremiumThe Fly
Roche price target raised to CHF 312 from CHF 305 at Morgan Stanley
29d ago
CHRO
H.C. Wainwright sees increased uncertainty for Sarepta franchise
PremiumThe Fly
H.C. Wainwright sees increased uncertainty for Sarepta franchise
29d ago
CHRO
SRPT
Roche’s Genentech present data on trontinemab, Elecsys plasma test
PremiumThe FlyRoche’s Genentech present data on trontinemab, Elecsys plasma test
30d ago
CHRO
Sarepta study pause brings approvability risk in Europe, says RBC
Premium
The Fly
Sarepta study pause brings approvability risk in Europe, says RBC
30d ago
CHRO
SRPT
EMA put clinical hold on Roche, Sarepta DMD studies after death
Premium
The Fly
EMA put clinical hold on Roche, Sarepta DMD studies after death
30d ago
CHRO
SRPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >